This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Hankook Pharm. Co., Inc., Other. Active years: 2000-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taejeon City, KR (2000)
- Daejeon, KR (2012)
Company Filing History:
Years Active: 2000-2012
Title: Man Woo Han: Innovator in Immunosuppressant Composition
Introduction
Man Woo Han is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of immunology through his innovative research and development. His work focuses on creating compositions that can inhibit transplant rejection and treat various skin diseases.
Latest Patents
Man Woo Han holds 1 patent for a composition aimed at preventing transplant rejection and treating skin conditions. This composition includes a natural extract as its active ingredient, which has been shown to significantly suppress the production of antibodies to transplants without causing side effects such as weight change. The non-toxic and harmless nature of this composition makes it suitable for use as an immunosuppressant in organ transplantation. Additionally, it is effective in stopping oozing from sores and is beneficial in treating skin diseases, including atopy, allergic reactions, decubitus ulcers, pemphigus, and smallpox.
Career Highlights
Man Woo Han is associated with Hankook Pharm. Co., Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential to improve patient outcomes in organ transplantation and dermatological treatments.
Collaborations
Some of his notable coworkers include Jae Kuk Yoo and Chang-Uk Hur, who have collaborated with him on various projects within the company.
Conclusion
Man Woo Han's innovative contributions to immunology highlight the importance of natural compositions in medical treatments. His work not only addresses critical health issues but also paves the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile